BACKGROUND: Pakistan is one of the 3 remaining wild poliovirus endemic countries. We collected sera from children to assess the prevalence of poliovirus antibodies in selected high-risk areas for poliovirus transmission. METHODS: Children in 2 age groups (6-11 and 36-48 months) were randomly selected between November 2015 and March 2016 in 6 areas of Pakistan (Sindh Province: Karachi and Kashmore; Khyber Pakhtunkhwa Province: Peshawar, Bannu and Nowshera; Punjab Province: Faisalabad). After obtaining informed consent, basic demographic and vaccination history data were collected, 1 peripheral venipuncture was obtained, and assays to detect poliovirus (PV)-neutralizing antibodies were performed. RESULTS: A total of 1301 children were enrolled and had peripheral blood drawn that analyzed. Study subjects were evenly distributed among survey sites and age groups. Anti-polio seroprevalence differed significantly among geographic areas (P < 0.001); in the 6-11 months group, it ranged between 89% and 98%, 58% and 95%, and 74% and 96% for PV serotypes 1, 2 and 3, respectively; in 36-48 months group, it ranged between 99% and 100%, 95% and 100%, and 92% and 100% for PV 1, 2, and 3, respectively. Having received inactivate poliovirus vaccine, malnourishment (stunting) and educational level of parents were found to be associated with presence of anti-polio antibodies. CONCLUSION: The polio eradication program achieved overall high serologic protection; however, immunity gaps in young children in the high polio risk areas remain. These gaps enable sustained circulation of wild poliovirus type 1, and pose risk for emergence of vaccine-derived polioviruses. Focusing on the lowest socioeconomic strata of society, where malnutrition is most prevalent, could accelerate poliovirus eradication.
BACKGROUND: Pakistan is one of the 3 remaining wild poliovirus endemic countries. We collected sera from children to assess the prevalence of poliovirus antibodies in selected high-risk areas for poliovirus transmission. METHODS: Children in 2 age groups (6-11 and 36-48 months) were randomly selected between November 2015 and March 2016 in 6 areas of Pakistan (Sindh Province: Karachi and Kashmore; Khyber Pakhtunkhwa Province: Peshawar, Bannu and Nowshera; Punjab Province: Faisalabad). After obtaining informed consent, basic demographic and vaccination history data were collected, 1 peripheral venipuncture was obtained, and assays to detect poliovirus (PV)-neutralizing antibodies were performed. RESULTS: A total of 1301 children were enrolled and had peripheral blood drawn that analyzed. Study subjects were evenly distributed among survey sites and age groups. Anti-polio seroprevalence differed significantly among geographic areas (P < 0.001); in the 6-11 months group, it ranged between 89% and 98%, 58% and 95%, and 74% and 96% for PV serotypes 1, 2 and 3, respectively; in 36-48 months group, it ranged between 99% and 100%, 95% and 100%, and 92% and 100% for PV 1, 2, and 3, respectively. Having received inactivate poliovirus vaccine, malnourishment (stunting) and educational level of parents were found to be associated with presence of anti-polio antibodies. CONCLUSION: The polio eradication program achieved overall high serologic protection; however, immunity gaps in young children in the high polio risk areas remain. These gaps enable sustained circulation of wild poliovirus type 1, and pose risk for emergence of vaccine-derived polioviruses. Focusing on the lowest socioeconomic strata of society, where malnutrition is most prevalent, could accelerate poliovirus eradication.
Authors: Ma Habib; S Soofi; N Ali; R W Sutter; M Palansch; H Qureshi; T Akhtar; N A Molodecky; H Okayasu; Zulfiqar A Bhutta Journal: Vaccine Date: 2013-02-18 Impact factor: 3.641
Authors: Cristina V Cardemil; Concepcion Estivariz; Laxman Shrestha; Jeevan B Sherchand; Arun Sharma; Howard E Gary; M Steven Oberste; William C Weldon; Michael D Bowen; Jan Vinjé; W William Schluter; Abhijeet Anand; Ondrej Mach; Susan Y Chu Journal: Vaccine Date: 2016-04-13 Impact factor: 3.641
Authors: Subhash Chandir; Kabir U Ahamed; Abdullah H Baqui; Roland W Sutter; Hiromasa Okayasu; Mark A Pallansch; Mark S Oberste; Lawrence H Moulton; Neal A Halsey Journal: J Infect Dis Date: 2014-11-01 Impact factor: 5.226
Authors: Jagadish M Deshpande; Sunil Bahl; Bidyut K Sarkar; Concepción F Estívariz; Shamila Sharma; Chris Wolff; Raman Sethi; Surendra K Pathyarch; Vibhor Jain; Howard E Gary; Mark A Pallansch; Hamid Jafari Journal: J Infect Dis Date: 2014-11-01 Impact factor: 5.226
Authors: Deepa Gamage; Paba Palihawadana; Ondrej Mach; William C Weldon; Steven M Oberste; Roland W Sutter Journal: J Epidemiol Glob Health Date: 2015-07-09
Authors: Christopher H Hsu; Kathleen A Wannemuehler; Sajid Soofi; Mohd Mashal; Imtiaz Hussain; Zulfiqar A Bhutta; Larin McDuffie; William Weldon; Noha H Farag Journal: Vaccine Date: 2019-02-16 Impact factor: 3.641
Authors: Imtiaz Hussain; Ondrej Mach; Nasir A Hamid; Zaid S Bhatti; Deborah D Moore; M Steven Oberste; Shahid Khan; Hasan Khan; William C Weldon; Roland W Sutter; Zulfiqar A Bhutta; Sajid B Soofi Journal: Vaccine Date: 2018-03-03 Impact factor: 3.641